RT Journal Article
SR Electronic
T1 Acute Stroke Imaging Research Roadmap
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP e23
OP e30
VO 29
IS 5
A1 Wintermark, Max
A1 Albers, Gregory W.
A1 Alexandrov, Andrei V.
A1 Alger, Jeffry R.
A1 Bammer, Roland
A1 Baron, Jean-Claude
A1 Davis, Stephen
A1 Demaerschalk, Bart M.
A1 Derdeyn, Colin P.
A1 Donnan, Geoffrey A.
A1 Eastwood, James D.
A1 Fiebach, Jochen B.
A1 Fisher, Marc
A1 Furie, Karen L.
A1 Goldmakher, Gregory V.
A1 Hacke, Werner
A1 Kidwell, Chelsea S.
A1 Kloska, Stephan P.
A1 Köhrmann, Martin
A1 Koroshetz, Walter
A1 Lee, Ting-Yim
A1 Lees, Kennedy R.
A1 Lev, Michael H.
A1 Liebeskind, David S.
A1 Ostergaard, Leif
A1 Powers, William J.
A1 Provenzale, James
A1 Schellinger, Peter
A1 Silbergleit, Robert
A1 Sorensen, Alma Gregory
A1 Wardlaw, Joanna
A1 Wu, Ona
A1 Warach, Steven
YR 2008
UL http://www.ajnr.org/content/29/5/e23.abstract
AB The recent “Advanced Neuroimaging for Acute Stroke Treatment” meeting on September 7 and 8, 2007 in Washington DC, brought together stroke neurologists, neuroradiologists, emergency physicians, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), industry representatives, and members of the US Food and Drug Administration (FDA) to discuss the role of advanced neuroimaging in acute stroke treatment. The goals of the meeting were to assess state-of-the-art practice in terms of acute stroke imaging research and to propose specific recommendations regarding: (1) the standardization of perfusion and penumbral imaging techniques, (2) the validation of the accuracy and clinical utility of imaging markers of the ischemic penumbra, (3) the validation of imaging biomarkers relevant to clinical outcomes, and (4) the creation of a central repository to achieve these goals. The present article summarizes these recommendations and examines practical steps to achieve them.